Technical Analysis for ALVR - AlloVir, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Volume Surge | Other | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Earnings Movers | Other | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Volume Surge | Other | 2.52% | |
| Upper Bollinger Band Walk | Strength | 2.52% | |
| Earnings Movers | Other | 2.52% | |
| Inside Day | Range Contraction | 2.52% | |
| Above Upper BB | Strength | 2.52% |
| Alert | Time |
|---|---|
| Gap Down Partially Closed | about 21 hours ago |
| Gap Down Closed | about 21 hours ago |
| Reversed from Down | about 21 hours ago |
| Rose Above Previous Day's High | about 21 hours ago |
| 3x Volume Pace | about 21 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 10/31/2024
AlloVir is a leading late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in patients with severely weakened immune systems. The company’s innovative and proprietary technology platforms leverage off-the-shelf, allogeneic, multi-virus specific T cells targeting devastating viruses for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. AlloVir’s technology and manufacturing process enables the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Immune System Stem Cell Cell Therapy Gene Therapy Cell Biology Manufacturing Process Viruses Virus Viral Disease Immunity Covid 19 Zoonoses
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Immune System Stem Cell Cell Therapy Gene Therapy Cell Biology Manufacturing Process Viruses Virus Viral Disease Immunity Covid 19 Zoonoses
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.485 |
| 52 Week Low | 0.58 |
| Average Volume | 194,982 |
| 200-Day Moving Average | 0.76 |
| 50-Day Moving Average | 0.79 |
| 20-Day Moving Average | 0.82 |
| 10-Day Moving Average | 0.84 |
| Average True Range | 0.06 |
| RSI (14) | 73.54 |
| ADX | 22.68 |
| +DI | 25.73 |
| -DI | 7.23 |
| Chandelier Exit (Long, 3 ATRs) | 0.79 |
| Chandelier Exit (Short, 3 ATRs) | 0.92 |
| Upper Bollinger Bands | 0.93 |
| Lower Bollinger Band | 0.72 |
| Percent B (%b) | 1.1 |
| BandWidth | 26.19 |
| MACD Line | 0.03 |
| MACD Signal Line | 0.02 |
| MACD Histogram | 0.0161 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.10 | ||||
| Resistance 3 (R3) | 1.09 | 1.03 | 1.08 | ||
| Resistance 2 (R2) | 1.03 | 0.99 | 1.04 | 1.07 | |
| Resistance 1 (R1) | 0.99 | 0.97 | 1.01 | 1.00 | 1.06 |
| Pivot Point | 0.93 | 0.93 | 0.94 | 0.94 | 0.93 |
| Support 1 (S1) | 0.89 | 0.89 | 0.91 | 0.90 | 0.85 |
| Support 2 (S2) | 0.83 | 0.87 | 0.84 | 0.84 | |
| Support 3 (S3) | 0.79 | 0.83 | 0.83 | ||
| Support 4 (S4) | 0.80 |
